Skip to main content
Log in

Intake of heterocyclic aromatic amines and the risk of prostate cancer in the EPIC-Heidelberg cohort

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Background

Heterocyclic amines (HCA) are positively associated with prostate cancer risk in animal models. Because of mostly inconsistent results of epidemiological studies, we examined the association between intake of HCA and prostate cancer risk.

Methods

In the EPIC-Heidelberg cohort, detailed information on diet, anthropometry, and lifestyle was assessed between 1994 and 1998. Dietary HCA intake was estimated using information on meat consumption, cooking methods, and preferred degree of browning. During 104,195 person-years of follow-up, 337 incident cases of prostate cancer (123 advanced cases) were identified among 9,578 men with valid dietary information. Multivariate Cox proportional hazards regression was used to examine the association between intake of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-3,4,8-dimethylimidazo[4,5-f]quinoxaline (DiMeIQx) and prostate cancer.

Results

Men in the highest quartiles of PhIP, MeIQx, and DiMeIQx intake, respectively, had no increased risk of prostate cancer compared with men in the lowest quartiles (HR = 0.89, 95% CI 0.66–1.22 [PhIP]; 1.06, 0.77–1.45 [MeIQx]; 0.98, 0.72–1.34 [DiMeIQx]). There were no associations between HCA intake and advanced prostate cancer or between high consumption of strongly browned meat and prostate cancer.

Discussion

Our data do not support the hypothesis that HCA intake as consumed in a regular diet is a risk factor for prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Felton JS, Knize MG, Wu RW, Colvin ME, Hatch FT, Malfatti MA (2007) Mutagenic potency of food-derived heterocyclic amines. Mutat Res 616:90–94

    CAS  PubMed  Google Scholar 

  2. Archer CL, Morse P, Jones RF, Shirai T, Haas GP, Wang CY (2000) Carcinogenicity of the N-hydroxy derivative of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine, 2-amino-3, 8-dimethyl-imidazo[4, 5-f]quinoxaline and 3, 2’-dimethyl-4-aminobiphenyl in the rat. Cancer Lett 155:55–60

    Article  CAS  PubMed  Google Scholar 

  3. Nakai Y, Nelson WG, De Marzo AM (2007) The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. Cancer Res 67:1378–1384

    Article  CAS  PubMed  Google Scholar 

  4. Sinha R, Gustafson DR, Kulldorff M, Wen WQ, Cerhan JR, Zheng W (2000) 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. J Natl Cancer Inst 92:1352–1354

    Article  CAS  PubMed  Google Scholar 

  5. Zheng W, Lee S (2009) Well-done meat intake, heterocyclic amine exposure, and cancer risk. Nutr Cancer 61:437–446

    Article  CAS  PubMed  Google Scholar 

  6. Rohrmann S, Hermann S, Linseisen J (2009) Heterocyclic aromatic amine intake increases colorectal adenoma risk: findings from a prospective European cohort study. Am J Clin Nutr 89:1418–1424

    Article  CAS  PubMed  Google Scholar 

  7. Koutros S, Cross AJ, Sandler DP et al (2008) Meat and meat mutagens and risk of prostate cancer in the agricultural Health study. Cancer Epidemiol Biomarkers Prev 17:80–87

    Article  CAS  PubMed  Google Scholar 

  8. Norrish AE, Ferguson LR, Knize MG, Felton JS, Sharpe SJ, Jackson RT (1999) Heterocyclic amine content of cooked meat and risk of prostate cancer. J Natl Cancer Inst 91:2038–2044

    Article  CAS  PubMed  Google Scholar 

  9. Cross AJ, Peters U, Kirsh VA et al (2005) A prospective study of meat and meat mutagens and prostate cancer risk. Cancer Res 65:11779–11784

    Article  CAS  PubMed  Google Scholar 

  10. Sinha R, Park Y, Graubard BI et al (2009) Meat and meat-related compounds and risk of prostate cancer in a large prospective cohort study in the United States. Am J Epidemiol 170:1165–1177

    Article  PubMed  Google Scholar 

  11. Rohrmann S, Platz EA, Kavanaugh CJ, Thuita L, Hoffman SC, Helzlsouer KJ (2007) Meat and dairy consumption and subsequent risk of prostate cancer in a US cohort study. Cancer Causes Control 18:41–50

    Article  PubMed  Google Scholar 

  12. Cross AJ, Leitzmann MF, Gail MH, Hollenbeck AR, Schatzkin A, Sinha R (2007) A prospective study of red and processed meat intake in relation to cancer risk. PLoS Med 4:e325

    Article  PubMed  Google Scholar 

  13. Michaud DS, Augustsson K, Rimm EB, Stampfer MJ, Willet WC, Giovannucci E (2001) A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes Control 12:557–567

    Article  CAS  PubMed  Google Scholar 

  14. Riboli E (2001) The European prospective investigation into cancer and nutrition (EPIC): plans and progress. J Nutr 131:170–175

    Google Scholar 

  15. Bergmann MM, Bussas U, Boeing H (1999) Follow-up procedures in EPIC-Germany-data quality aspects. European prospective investigation into cancer and nutrition. Ann Nutr Metab 43:225–234

    Article  CAS  PubMed  Google Scholar 

  16. Bohlscheid Thomas S, Hoting I, Boeing H, Wahrendorf J (1997) Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European prospective investigation into cancer and nutrition. Int J Epidemiol 26:59–70

    Article  Google Scholar 

  17. Rohrmann S, Zoller D, Hermann S, Lineisen J (2007) Intake of heterocyclic aromatic amines from meat in the European prospective investigation into cancer and nutrition (EPIC)-Heidelberg cohort. Br J Nutr 98:1112–1115

    Article  CAS  PubMed  Google Scholar 

  18. Allen NE, Key TJ, Appleby PN et al (2008) Animal foods, protein, calcium and prostate cancer risk: the European prospective investigation into cancer and nutrition. Br J Cancer 98:1574–1581

    Article  CAS  PubMed  Google Scholar 

  19. Skog K (2002) Problems associated with the determination of heterocyclic amines in cooked foods and human exposure. Food Chem Toxicol 40:1197–1203

    Article  CAS  PubMed  Google Scholar 

  20. Sinha R (2002) An epidemiological approach to studying heterocyclic amines. Mutat Res 506–507:197–204

    PubMed  Google Scholar 

  21. Kobayashi M, Hanaoka T, Tsugane S (2007) Validity of a self-administered food frequency questionnaire in the assessment of heterocyclic amine intake using 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) levels in hair. Mutat Res 630:14–19

    CAS  PubMed  Google Scholar 

  22. Shirai T, Sano M, Tamano S et al (1997) The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine (PhIP) derived from cooked foods. Cancer Re 57:195–198

    CAS  Google Scholar 

  23. Tappel A (2007) Heme of consumed red meat can act as a catalyst of oxidative damage and could initiate colon, breast and prostate cancers, heart disease and other diseases. Med Hypotheses 68:562–564

    Article  CAS  PubMed  Google Scholar 

  24. Koutros S, Brendt SI, Sinha R et al (2009) Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer. Cancer Res 69:1877–1884

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was partly supported by Kurt-Eberhard-Bode-Foundation and ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a Network of Excellence of the European Commission (Contract No 513943).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sabine Rohrmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sander, A., Linseisen, J. & Rohrmann, S. Intake of heterocyclic aromatic amines and the risk of prostate cancer in the EPIC-Heidelberg cohort. Cancer Causes Control 22, 109–114 (2011). https://doi.org/10.1007/s10552-010-9680-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-010-9680-9

Keywords

Navigation